Clinical trials for Inflammatory bowel disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Inflammatory bowel disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Inflammatory bowel disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Inflammatory bowel disease
Title Recruitment status Location
AN OPEN LABEL EXTENSION AND SAFETY MONITORING STUDY OF MODERATE TO SEVERE ULCERATIVE COLITIS PATIENTS PREVIOUSLY ENROLLED IN ETROLIZUMAB PHASE III STUDIES Recruiting United Kingdom
PHASE III, DOUBLE BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ETROLIZUMAB DURING INDUCTION AND MAINTENANCE IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS WHO ARE REFRACTORY TO OR INTOLERANT OF TNF INHIBITORS Recruiting United Kingdom
Understanding the impact of Ulcerative Colitis and its associated disease burden on patients Recruiting United Kingdom
Ibd CAncer and seRious infections in Europe Recruiting United Kingdom
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients with Moderate to Severe Ulcerative Colitis Not Recruiting United Kingdom
A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Ulcerative Colitis Not Recruiting United Kingdom
Study of MLN0002 in Patients With Moderate to Severe Crohns Disease Not Recruiting United Kingdom
Study of MLN0002 in Patients With Moderate to Severe Ulcerative Colitis Not Recruiting United Kingdom
Evaluation of efficacy and safety of tralokinumab in patients with active, moderate-to-severe ulcerative colitis. Not Recruiting United Kingdom
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS - ND Not Recruiting United Kingdom

Page last reviewed:

Next review due: